Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2006 1
2007 3
2008 2
2009 2
2010 3
2011 7
2012 4
2013 6
2014 13
2015 16
2016 17
2017 39
2018 43
2019 61
2020 101
2021 162
2022 234
2023 342
2024 108

Text availability

Article attribute

Article type

Publication date

Search Results

1,007 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Jang
Page 1
Showing results for hanmi%20Jang
Your search for Hanme%20Jang retrieved no results
Non-alcoholic fatty liver disease.
Powell EE, Wong VW, Rinella M. Powell EE, et al. Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21. Lancet. 2021. PMID: 33894145 Review.
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials.
Sattar N, Lee MMY, Kristensen SL, Branch KRH, Del Prato S, Khurmi NS, Lam CSP, Lopes RD, McMurray JJV, Pratley RE, Rosenstock J, Gerstein HC. Sattar N, et al. Lancet Diabetes Endocrinol. 2021 Oct;9(10):653-662. doi: 10.1016/S2213-8587(21)00203-5. Epub 2021 Aug 20. Lancet Diabetes Endocrinol. 2021. PMID: 34425083
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN; NAFLD Nomenclature consensus group. Rinella ME, et al. Hepatology. 2023 Dec 1;78(6):1966-1986. doi: 10.1097/HEP.0000000000000520. Epub 2023 Jun 24. Hepatology. 2023. PMID: 37363821 Free PMC article.
Nonalcoholic fatty liver disease: another leap forward.
Abdelmalek MF. Abdelmalek MF. Nat Rev Gastroenterol Hepatol. 2021 Feb;18(2):85-86. doi: 10.1038/s41575-020-00406-0. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33420415 Free PMC article. Review.
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial.
Kim BK, Hong SJ, Lee YJ, Hong SJ, Yun KH, Hong BK, Heo JH, Rha SW, Cho YH, Lee SJ, Ahn CM, Kim JS, Ko YG, Choi D, Jang Y, Hong MK; RACING investigators. Kim BK, et al. Lancet. 2022 Jul 30;400(10349):380-390. doi: 10.1016/S0140-6736(22)00916-3. Epub 2022 Jul 18. Lancet. 2022. PMID: 35863366 Clinical Trial.
INTERPRETATION: Among patients with ASCVD, moderate-intensity statin with ezetimibe combination therapy was non-inferior to high-intensity statin monotherapy for the 3-year composite outcomes with a higher proportion of patients with LDL cholesterol concentrations of less than 70 …
INTERPRETATION: Among patients with ASCVD, moderate-intensity statin with ezetimibe combination therapy was non-inferior to high-intensity s …
Iron overload disorders.
Hsu CC, Senussi NH, Fertrin KY, Kowdley KV. Hsu CC, et al. Hepatol Commun. 2022 Aug;6(8):1842-1854. doi: 10.1002/hep4.2012. Epub 2022 Jun 14. Hepatol Commun. 2022. PMID: 35699322 Free PMC article. Review.
Applications of artificial intelligence for hypertension management.
Tsoi K, Yiu K, Lee H, Cheng HM, Wang TD, Tay JC, Teo BW, Turana Y, Soenarta AA, Sogunuru GP, Siddique S, Chia YC, Shin J, Chen CH, Wang JG, Kario K; HOPE Asia Network. Tsoi K, et al. J Clin Hypertens (Greenwich). 2021 Mar;23(3):568-574. doi: 10.1111/jch.14180. Epub 2021 Feb 3. J Clin Hypertens (Greenwich). 2021. PMID: 33533536 Free PMC article. Review.
1,007 results